The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metronidazole Injection Market Research Report 2024
Synopsis
Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
The global Metronidazole Injection market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 30 million by 2030, witnessing a CAGR of -1.2% during the forecast period 2024-2030.
North American market for Metronidazole Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metronidazole Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Metronidazole Injection include Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc, Baxter, JB Chemicals and Pharmaceuticals, Qatar Pharma, Unique Pharmaceuticals, Sagent Pharmaceuticals and AdvaCare Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metronidazole Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metronidazole Injection.
Report Scope
The Metronidazole Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metronidazole Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metronidazole Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
Segment by Type
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metronidazole Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Metronidazole Injection is a sterile, parenteral dosage form of metronidazole in water. Metronidazole is classified as a synthetic antibacterial and antiprotozoal agent and is administered by the intravenous route. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Metronidazole Injection and other antibacterial drugs, Metronidazole Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection.
The global Metronidazole Injection market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 30 million by 2030, witnessing a CAGR of -1.2% during the forecast period 2024-2030.
North American market for Metronidazole Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metronidazole Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Metronidazole Injection include Pfizer, B. Braun Medical Inc, Sanofi-Aventis Canada Inc, Baxter, JB Chemicals and Pharmaceuticals, Qatar Pharma, Unique Pharmaceuticals, Sagent Pharmaceuticals and AdvaCare Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metronidazole Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metronidazole Injection.
Report Scope
The Metronidazole Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metronidazole Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metronidazole Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
B. Braun Medical Inc
Sanofi-Aventis Canada Inc
Baxter
JB Chemicals and Pharmaceuticals
Qatar Pharma
Unique Pharmaceuticals
Sagent Pharmaceuticals
AdvaCare Pharma
Segment by Type
500mg/100mL
50mg/10mL
Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metronidazole Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Metronidazole Injection Market Overview
1.1 Product Overview and Scope of Metronidazole Injection
1.2 Metronidazole Injection Segment by Type
1.2.1 Global Metronidazole Injection Market Value Comparison by Type (2024-2030)
1.2.2 500mg/100mL
1.2.3 50mg/10mL
1.3 Metronidazole Injection Segment by Application
1.3.1 Global Metronidazole Injection Market Value by Application: (2024-2030)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.3.4 Geriatric Use
1.4 Global Metronidazole Injection Market Size Estimates and Forecasts
1.4.1 Global Metronidazole Injection Revenue 2019-2030
1.4.2 Global Metronidazole Injection Sales 2019-2030
1.4.3 Global Metronidazole Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Metronidazole Injection Market Competition by Manufacturers
2.1 Global Metronidazole Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Metronidazole Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Metronidazole Injection Average Price by Manufacturers (2019-2024)
2.4 Global Metronidazole Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metronidazole Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metronidazole Injection, Product Type & Application
2.7 Metronidazole Injection Market Competitive Situation and Trends
2.7.1 Metronidazole Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Metronidazole Injection Players Market Share by Revenue
2.7.3 Global Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metronidazole Injection Retrospective Market Scenario by Region
3.1 Global Metronidazole Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Metronidazole Injection Global Metronidazole Injection Sales by Region: 2019-2030
3.2.1 Global Metronidazole Injection Sales by Region: 2019-2024
3.2.2 Global Metronidazole Injection Sales by Region: 2025-2030
3.3 Global Metronidazole Injection Global Metronidazole Injection Revenue by Region: 2019-2030
3.3.1 Global Metronidazole Injection Revenue by Region: 2019-2024
3.3.2 Global Metronidazole Injection Revenue by Region: 2025-2030
3.4 North America Metronidazole Injection Market Facts & Figures by Country
3.4.1 North America Metronidazole Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Metronidazole Injection Sales by Country (2019-2030)
3.4.3 North America Metronidazole Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Metronidazole Injection Market Facts & Figures by Country
3.5.1 Europe Metronidazole Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Metronidazole Injection Sales by Country (2019-2030)
3.5.3 Europe Metronidazole Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metronidazole Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Metronidazole Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Metronidazole Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Metronidazole Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Metronidazole Injection Market Facts & Figures by Country
3.7.1 Latin America Metronidazole Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Metronidazole Injection Sales by Country (2019-2030)
3.7.3 Latin America Metronidazole Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metronidazole Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Metronidazole Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Metronidazole Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Metronidazole Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metronidazole Injection Sales by Type (2019-2030)
4.1.1 Global Metronidazole Injection Sales by Type (2019-2024)
4.1.2 Global Metronidazole Injection Sales by Type (2025-2030)
4.1.3 Global Metronidazole Injection Sales Market Share by Type (2019-2030)
4.2 Global Metronidazole Injection Revenue by Type (2019-2030)
4.2.1 Global Metronidazole Injection Revenue by Type (2019-2024)
4.2.2 Global Metronidazole Injection Revenue by Type (2025-2030)
4.2.3 Global Metronidazole Injection Revenue Market Share by Type (2019-2030)
4.3 Global Metronidazole Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Metronidazole Injection Sales by Application (2019-2030)
5.1.1 Global Metronidazole Injection Sales by Application (2019-2024)
5.1.2 Global Metronidazole Injection Sales by Application (2025-2030)
5.1.3 Global Metronidazole Injection Sales Market Share by Application (2019-2030)
5.2 Global Metronidazole Injection Revenue by Application (2019-2030)
5.2.1 Global Metronidazole Injection Revenue by Application (2019-2024)
5.2.2 Global Metronidazole Injection Revenue by Application (2025-2030)
5.2.3 Global Metronidazole Injection Revenue Market Share by Application (2019-2030)
5.3 Global Metronidazole Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Metronidazole Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 B. Braun Medical Inc
6.2.1 B. Braun Medical Inc Corporation Information
6.2.2 B. Braun Medical Inc Description and Business Overview
6.2.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
6.2.5 B. Braun Medical Inc Recent Developments/Updates
6.3 Sanofi-Aventis Canada Inc
6.3.1 Sanofi-Aventis Canada Inc Corporation Information
6.3.2 Sanofi-Aventis Canada Inc Description and Business Overview
6.3.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
6.3.5 Sanofi-Aventis Canada Inc Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Corporation Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter Metronidazole Injection Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 JB Chemicals and Pharmaceuticals
6.5.1 JB Chemicals and Pharmaceuticals Corporation Information
6.5.2 JB Chemicals and Pharmaceuticals Description and Business Overview
6.5.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
6.5.5 JB Chemicals and Pharmaceuticals Recent Developments/Updates
6.6 Qatar Pharma
6.6.1 Qatar Pharma Corporation Information
6.6.2 Qatar Pharma Description and Business Overview
6.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
6.6.5 Qatar Pharma Recent Developments/Updates
6.7 Unique Pharmaceuticals
6.6.1 Unique Pharmaceuticals Corporation Information
6.6.2 Unique Pharmaceuticals Description and Business Overview
6.6.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
6.7.5 Unique Pharmaceuticals Recent Developments/Updates
6.8 Sagent Pharmaceuticals
6.8.1 Sagent Pharmaceuticals Corporation Information
6.8.2 Sagent Pharmaceuticals Description and Business Overview
6.8.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
6.8.5 Sagent Pharmaceuticals Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Corporation Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metronidazole Injection Industry Chain Analysis
7.2 Metronidazole Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metronidazole Injection Production Mode & Process
7.4 Metronidazole Injection Sales and Marketing
7.4.1 Metronidazole Injection Sales Channels
7.4.2 Metronidazole Injection Distributors
7.5 Metronidazole Injection Customers
8 Metronidazole Injection Market Dynamics
8.1 Metronidazole Injection Industry Trends
8.2 Metronidazole Injection Market Drivers
8.3 Metronidazole Injection Market Challenges
8.4 Metronidazole Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Metronidazole Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Metronidazole Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Metronidazole Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Metronidazole Injection Sales (KL) of Key Manufacturers (2019-2024)
Table 5. Global Metronidazole Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Metronidazole Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Metronidazole Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Metronidazole Injection Average Price (US$/L) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Metronidazole Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Metronidazole Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Metronidazole Injection, Product Type & Application
Table 12. Global Key Manufacturers of Metronidazole Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Metronidazole Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metronidazole Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Metronidazole Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Metronidazole Injection Sales by Region (2019-2024) & (KL)
Table 18. Global Metronidazole Injection Sales Market Share by Region (2019-2024)
Table 19. Global Metronidazole Injection Sales by Region (2025-2030) & (KL)
Table 20. Global Metronidazole Injection Sales Market Share by Region (2025-2030)
Table 21. Global Metronidazole Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Metronidazole Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Metronidazole Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Metronidazole Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Metronidazole Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Metronidazole Injection Sales by Country (2019-2024) & (KL)
Table 27. North America Metronidazole Injection Sales by Country (2025-2030) & (KL)
Table 28. North America Metronidazole Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Metronidazole Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Metronidazole Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Metronidazole Injection Sales by Country (2019-2024) & (KL)
Table 32. Europe Metronidazole Injection Sales by Country (2025-2030) & (KL)
Table 33. Europe Metronidazole Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Metronidazole Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Metronidazole Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Metronidazole Injection Sales by Region (2019-2024) & (KL)
Table 37. Asia Pacific Metronidazole Injection Sales by Region (2025-2030) & (KL)
Table 38. Asia Pacific Metronidazole Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Metronidazole Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metronidazole Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Metronidazole Injection Sales by Country (2019-2024) & (KL)
Table 42. Latin America Metronidazole Injection Sales by Country (2025-2030) & (KL)
Table 43. Latin America Metronidazole Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Metronidazole Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Metronidazole Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Metronidazole Injection Sales by Country (2019-2024) & (KL)
Table 47. Middle East & Africa Metronidazole Injection Sales by Country (2025-2030) & (KL)
Table 48. Middle East & Africa Metronidazole Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Metronidazole Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Metronidazole Injection Sales (KL) by Type (2019-2024)
Table 51. Global Metronidazole Injection Sales (KL) by Type (2025-2030)
Table 52. Global Metronidazole Injection Sales Market Share by Type (2019-2024)
Table 53. Global Metronidazole Injection Sales Market Share by Type (2025-2030)
Table 54. Global Metronidazole Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Metronidazole Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Metronidazole Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Metronidazole Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Metronidazole Injection Price (US$/L) by Type (2019-2024)
Table 59. Global Metronidazole Injection Price (US$/L) by Type (2025-2030)
Table 60. Global Metronidazole Injection Sales (KL) by Application (2019-2024)
Table 61. Global Metronidazole Injection Sales (KL) by Application (2025-2030)
Table 62. Global Metronidazole Injection Sales Market Share by Application (2019-2024)
Table 63. Global Metronidazole Injection Sales Market Share by Application (2025-2030)
Table 64. Global Metronidazole Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Metronidazole Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Metronidazole Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Metronidazole Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Metronidazole Injection Price (US$/L) by Application (2019-2024)
Table 69. Global Metronidazole Injection Price (US$/L) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 73. Pfizer Metronidazole Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. B. Braun Medical Inc Corporation Information
Table 76. B. Braun Medical Inc Description and Business Overview
Table 77. B. Braun Medical Inc Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 78. B. Braun Medical Inc Metronidazole Injection Product
Table 79. B. Braun Medical Inc Recent Developments/Updates
Table 80. Sanofi-Aventis Canada Inc Corporation Information
Table 81. Sanofi-Aventis Canada Inc Description and Business Overview
Table 82. Sanofi-Aventis Canada Inc Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 83. Sanofi-Aventis Canada Inc Metronidazole Injection Product
Table 84. Sanofi-Aventis Canada Inc Recent Developments/Updates
Table 85. Baxter Corporation Information
Table 86. Baxter Description and Business Overview
Table 87. Baxter Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 88. Baxter Metronidazole Injection Product
Table 89. Baxter Recent Developments/Updates
Table 90. JB Chemicals and Pharmaceuticals Corporation Information
Table 91. JB Chemicals and Pharmaceuticals Description and Business Overview
Table 92. JB Chemicals and Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 93. JB Chemicals and Pharmaceuticals Metronidazole Injection Product
Table 94. JB Chemicals and Pharmaceuticals Recent Developments/Updates
Table 95. Qatar Pharma Corporation Information
Table 96. Qatar Pharma Description and Business Overview
Table 97. Qatar Pharma Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 98. Qatar Pharma Metronidazole Injection Product
Table 99. Qatar Pharma Recent Developments/Updates
Table 100. Unique Pharmaceuticals Corporation Information
Table 101. Unique Pharmaceuticals Description and Business Overview
Table 102. Unique Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 103. Unique Pharmaceuticals Metronidazole Injection Product
Table 104. Unique Pharmaceuticals Recent Developments/Updates
Table 105. Sagent Pharmaceuticals Corporation Information
Table 106. Sagent Pharmaceuticals Description and Business Overview
Table 107. Sagent Pharmaceuticals Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 108. Sagent Pharmaceuticals Metronidazole Injection Product
Table 109. Sagent Pharmaceuticals Recent Developments/Updates
Table 110. AdvaCare Pharma Corporation Information
Table 111. AdvaCare Pharma Description and Business Overview
Table 112. AdvaCare Pharma Metronidazole Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2019-2024)
Table 113. AdvaCare Pharma Metronidazole Injection Product
Table 114. AdvaCare Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Metronidazole Injection Distributors List
Table 118. Metronidazole Injection Customers List
Table 119. Metronidazole Injection Market Trends
Table 120. Metronidazole Injection Market Drivers
Table 121. Metronidazole Injection Market Challenges
Table 122. Metronidazole Injection Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metronidazole Injection
Figure 2. Global Metronidazole Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Metronidazole Injection Market Share by Type in 2023 & 2030
Figure 4. 500mg/100mL Product Picture
Figure 5. 50mg/10mL Product Picture
Figure 6. Global Metronidazole Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Metronidazole Injection Market Share by Application in 2023 & 2030
Figure 8. Adult Use
Figure 9. Pediatric Use
Figure 10. Geriatric Use
Figure 11. Global Metronidazole Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Metronidazole Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Metronidazole Injection Sales (2019-2030) & (KL)
Figure 14. Global Metronidazole Injection Average Price (US$/L) & (2019-2030)
Figure 15. Metronidazole Injection Report Years Considered
Figure 16. Metronidazole Injection Sales Share by Manufacturers in 2023
Figure 17. Global Metronidazole Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Metronidazole Injection Players: Market Share by Revenue in 2023
Figure 19. Metronidazole Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Metronidazole Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Metronidazole Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Metronidazole Injection Revenue Market Share by Country (2019-2030)
Figure 23. United States Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Metronidazole Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Metronidazole Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Metronidazole Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Metronidazole Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Metronidazole Injection Sales Market Share by Country (2019-2030)
Figure 44. Latin America Metronidazole Injection Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Metronidazole Injection Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Metronidazole Injection Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Metronidazole Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Metronidazole Injection by Type (2019-2030)
Figure 54. Global Revenue Market Share of Metronidazole Injection by Type (2019-2030)
Figure 55. Global Metronidazole Injection Price (US$/L) by Type (2019-2030)
Figure 56. Global Sales Market Share of Metronidazole Injection by Application (2019-2030)
Figure 57. Global Revenue Market Share of Metronidazole Injection by Application (2019-2030)
Figure 58. Global Metronidazole Injection Price (US$/L) by Application (2019-2030)
Figure 59. Metronidazole Injection Value Chain
Figure 60. Metronidazole Injection Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
